VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of LUMIFY EYE ILLUMINATIONS, a new line of hypoallergenic specialty eye care products scientifically developed to cleanse, nourish and brighten the sensitive eye area..

安大略省沃恩市-（商业线）-博士伦公司（NYSE/TSX:BLCO）是一家领先的全球眼保健公司，致力于帮助人们看到更好的生活，今天宣布美国推出LUMIFY eye Illumations，这是一种新型的低过敏专业眼保健产品，科学开发，用于清洁，滋养和照亮敏感的眼部区域。。

“Many products contain chemicals or preservatives that can irritate the delicate area of and around the eye,” said John Ferris, executive vice president, Consumer, Bausch + Lomb. “Free from harsh, irritating ingredients, LUMIFY EYE ILLUMINATIONS were developed with both ophthalmologists and dermatologists and are clinically proven to deliver visibly beautiful results.”.

博士伦消费者执行副总裁约翰·费里斯（John Ferris）说：“许多产品含有可刺激眼睛周围微妙区域的化学物质或防腐剂。“没有刺激性的刺激性成分，LUMIFY眼罩与眼科医生和皮肤科医生共同开发，临床证明可以提供明显美丽的效果。”。

Each product in the LUMIFY EYE ILLUMINATIONS line has been formulated with clean, nutrient rich ingredients and contains no fragrance, alcohol, sulfates, mineral oil, prostaglandins, PEG (polyethylene glycol), parabens, phthalates or PHMB (polyhexamethylene biguanide). In addition, the safety and performance of the products were tested up to 12 weeks with more than 15,000 applications using cutaneous and ophthalmic testing metrics..

LUMIFY EYE照明系列中的每种产品均配制有清洁，营养丰富的成分，不含香料，酒精，硫酸盐，矿物油，前列腺素，PEG（聚乙二醇），对羟基苯甲酸酯，邻苯二甲酸酯或PHMB（聚六亚甲基双胍）。此外，使用皮肤和眼科测试指标，产品的安全性和性能经过长达12周的测试，应用程序超过15000次。。

The LUMIFY EYE ILLUMINATIONS product line, which builds on the success of LUMIFY® redness reliever eye drops, includes:

LUMIFY EYE ILLUMINATIONS产品系列基于LUMIFY®redness reliever滴眼液的成功，包括：

LUMIFY EYE ILLUMINATIONS 3-in-1 Micellar Cleansing Water and Eye Makeup Remover – this unique, lash extension friendly, no-rinse micellar formula provides powerful cleansing while hyaluronic acid, vitamin C and niacinamide moisturize and brighten the delicate skin around the eyes. The solution removes waterproof makeup without harsh rubbing and is pH-balanced to be non-irritating..

LUMIFY EYE ILLUMINATIONS 3合1胶束清洁水和眼罩去除剂-这种独特，睫毛延伸友好，无冲洗的胶束配方可提供强大的清洁效果，同时透明质酸，维生素C和烟酰胺保湿，照亮眼睛周围的精致皮肤。该溶液可去除防水化妆品，不会剧烈摩擦，pH平衡，无刺激性。。

In clinical studies, subjects’ skin looked brighter, smoother and more radiant within just two weeks. By week eight, more than 75% of respondents felt their skin looked healthier and rejuvenated with an improved texture.

在临床研究中，受试者的皮肤在短短两周内看起来更亮，更光滑，更辐射。到第八周，超过75%的受访者认为他们的皮肤看起来更健康，质地得到改善。

LUMIFY EYE ILLUMINATIONS Nourishing Lash & Brow Serum – a unique complex of peptides, biotin and moisturizing hyaluronic acid nourish, soften and condition lashes and brows overnight. In clinical studies, noticeably fuller looking lashes and brows were seen in just four weeks. The two-in-one serum includes an easy-to-use applicator for both lashes and brows and dries quickly without feeling greasy or sticky..

LUMIFY眼罩照亮睫毛和眉毛血清-肽，生物素和保湿透明质酸的独特复合物-过夜滋养，软化和调节睫毛和眉毛。在临床研究中，仅四周就可以看到明显更丰满的睫毛和眉毛。二合一血清包括易于使用的睫毛和眉毛涂抹器，可快速干燥而不会感到油腻或粘稠。。

In clinical studies, nearly 80% of subjects showed an improvement in the appearance of lash volume at 12 weeks, and 91% showed an improvement in the appearance of brow thickness.

在临床研究中，近80%的受试者在12周时表现出睫毛体积外观的改善，91%表现出眉毛厚度外观的改善。

LUMIFY EYE ILLUMINATIONS Hydra-Gel Brightening Eye Cream – a unique blend of optic brighteners and firming ingredients helps skin look brighter and smoother with a subtle glow. Niacinamide, vitamins C and E, caffeine and hyaluronic acid help improve the appearance of skin tone, texture, fine lines and wrinkles with daily use..

LUMIFY EYE ILLUMINATIONS Hydra Gel增亮眼霜-独特的光学增白剂和紧致成分混合物，可帮助皮肤看起来更明亮，更光滑，具有微妙的光泽。烟酰胺，维生素C和E，咖啡因和透明质酸有助于改善肤色，质地，细纹和皱纹的外观。。

By week 12 in clinical studies, approximately 70% of respondents noticed a reduction in the appearance of fine lines and wrinkles.

到临床研究的第12周，大约70%的受访者注意到细纹和皱纹的出现减少。

“An increasing number of my patients have experienced eye irritation associated with some of the products or treatments they use around their eyes,” said Jennifer Tsai, O.D., and founder, LINE OF SIGHT, New York. “LUMIFY EYE ILLUMINATIONS was developed specifically for the sensitive eye area with extensive safety and performance testing.

O.D.和纽约视线创始人Jennifer Tsai说：“越来越多的我的患者经历了与他们在眼睛周围使用的某些产品或治疗相关的眼睛刺激。“LUMIFY眼睛照明是专门为敏感的眼睛区域开发的，具有广泛的安全性和性能测试。

I’ll be recommending this new line of products to help my patients achieve beautiful, healthy-looking eyes.”.

我会推荐这一新产品系列，以帮助我的患者获得美丽，健康的眼睛。”。

LUMIFY EYE ILLUMINATIONS are located in the eye care aisle next to Bausch + Lomb LUMIFY redness reliever eye drops and are also available online at all major national food, drug and mass retailers.

LUMIFY眼罩位于Bausch+Lomb LUMIFY redness reliever滴眼液旁边的眼保健通道，也可在所有主要的国家食品，药品和大众零售商在线获得。

For more information on LUMIFY EYE ILLUMINATIONS, visit www.lumifyeyes.com.

有关LUMIFY EYE照明的更多信息，请访问www.lumifyeyes.com。

About the LUMIFY Brand

关于LUMIFY品牌

The LUMIFY brand began in 2018 with the U.S. introduction of LUMIFY redness reliever eye drops, which are the first and only over-the-counter eye drop formulated with low-dose brimonidine tartrate 0.025% for the treatment of ocular redness. They are the No. 1 eye doctor recommended redness reliever eye drop brand with approximately 90% of doctor recommendations1, and they have received more than a dozen awards, including Glamour's 'The Best Beauty Innovators of 2022' award.

LUMIFY品牌于2018年开始推出，美国推出LUMIFY redness reliever滴眼液，这是第一种也是唯一一种用低剂量酒石酸溴莫尼定0.025%配制的非处方滴眼液，用于治疗眼部发红。他们是第一眼医生推荐的红肿缓解眼药水品牌，约有90%的医生建议1，他们获得了十几项奖项，其中包括Glamour的“2022年最佳美容创新者”奖。

In 2023, Bausch + Lomb introduced LUMIFY EYE ILLUMINATIONS, a new line of specialty eye care products specifically developed for the sensitive area around the eyes. For more information on the LUMIFY brand, visit www.lumifyeyes.com..

2023年，博士伦（Bausch+Lomb）推出了LUMIFY EYE Illumations，这是一系列专门为眼睛周围敏感区域开发的专业眼保健产品。有关LUMIFY品牌的更多信息，请访问www.lumifyeyes.com。。

About Bausch + Lomb

关于Bausch

Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Its comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments.

博士伦致力于保护和增强世界各地数百万人的视力礼物-从出生到生命的每个阶段。其全面的400多种产品组合包括隐形眼镜，镜片护理产品，眼保健产品，眼科药物，非处方产品以及眼科手术器械和器械。

Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on Twitter, LinkedIn, Facebook and Instagram..

博士伦成立于1853年，拥有重要的全球研发，制造和商业足迹，约有13000名员工，并在近100个国家/地区设有。博士伦总部设在安大略省沃恩市，公司总部设在新泽西州布里奇沃特。欲了解更多信息，请访问www.bausch.com并在Twitter，LinkedIn，Facebook和Instagram上与我们联系。。

Forward-looking Statements

前瞻性声明

This news release may contain forward-looking statements, which may generally be identified by the use of the words “anticipates,” “hopes,” “expects,” “intends,” “plans,” “should,” “could,” “would,” “may,” “believes,” “estimates,” “potential,” “target,” or “continue” and variations or similar expressions.

该新闻稿可能包含前瞻性陈述，通常可以通过使用“预期”，“希望”，“期望”，“意图”，“计划”，“应该”，“可以”，“将会”，“可以”相信，“估计”，“潜力”，“目标”或“继续”以及变体或类似表达。

These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, the risks and uncertainties discussed in Bausch + Lomb’s filings with the U.S.

这些声明基于当前对管理层的期望和信念，并且存在某些风险和不确定性，可能导致实际结果与前瞻性声明中描述的结果大不相同。这些风险和不确定性包括但不限于博士伦与美国的文件中讨论的风险和不确定性。

Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Bausch + Lomb undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law..

证券交易委员会和加拿大证券管理员，这些因素通过引用并入本文。提醒读者不要过分依赖这些前瞻性陈述。这些前瞻性声明仅在本协议签署之日起生效。除非法律要求，否则博士伦不承担更新任何这些前瞻性陈述的义务，以反映本新闻发布之日以后的事件或情况或反映实际结果。。

*at eight weeks

*八周后

References

工具书类

IQVIA, Average Share of Weekly Doctor Recommendations, Q2 2023.

IQVIA，每周医生建议的平均份额，Q2 2023。

© 2023 Bausch + Lomb.

© 2023 Bausch Lomb。

LUM.0061.USA.23

卢姆0061美国23